Search results
Results from the WOW.Com Content Network
SUPPORT for Patients and Communities Act, also known as Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, (H.R. 6, Pub. L. 115–271 (text)) is a United States federal law, enacted during the 115th United States Congress, to make medical treatment for opioid addiction more widely available while also cracking down on illicit drugs.
Addiction medicine is a medical subspecialty that deals with the diagnosis, prevention, evaluation, treatment, and recovery of persons with addiction, of those with substance-related and addictive disorders, and of people who show unhealthy use of substances including alcohol, nicotine, prescription medicine and other illicit and licit drugs. [3]
The Drug Addiction Treatment Act of 2000 (DATA 2000), Title XXXV, Section 3502 of the Children's Health Act, permits physicians who meet certain qualifications to treat opioid addiction with Schedule III, IV, and V narcotic medications that have been specifically approved by the Food and Drug Administration for that indication.
Drug rehabilitation is the process of medical or psychotherapeutic treatment for dependency on psychoactive substances such as alcohol, prescription drugs, and street drugs such as cannabis, cocaine, heroin, and amphetamines.
Addiction psychiatry encompasses both medicine and psychotherapy, or professional therapeutic interaction, as the means of treating individuals. In a conventional addiction psychiatry session, addiction psychiatrists will gain a better understanding of their patient's lifestyle by gathering medical history and the patient's mental health concerns.
An Act to amend the Public Health Service Act and other laws to provide increased research, into, and prevention of, drug abuse and drug dependence; to provide for treatment and rehabilitation of drug abusers and drug dependent persons; and to strengthen existing law enforcement authority in the field of drug abuse.
Addiction is a progressive psychiatric disorder that is defined by the American Society of Addiction Medicine as "a primary, chronic disease of brain reward, motivation, memory and related circuitry." It is characterized by the inability to control behavior, it creates a dysfunctional emotional response, and it affects the users ability to ...
The hijack model of substance addiction suggests that Psychoactive drugs act on ancient and evolutionarily conserved neural mechanisms associated with positive emotions that evolved to mediate incentive behavior. [1] [2] They induce emotions that in human evolutionary history signaled a benefit for the group. Modern drugs tap into these ...